Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 May;79(5):1440–1446. doi: 10.1172/JCI112972

Inhibition of human endothelial cell proliferation by gold compounds.

T Matsubara, M Ziff
PMCID: PMC424416  PMID: 3106416

Abstract

Neovascularization has a role in the propagation of rheumatoid synovitis because the spread of mononuclear cell infiltration and the growth of pannus are dependent on the growth of new blood vessels. Growth of such vessels requires local endothelial cell (EC) proliferation. Inhibition of synovial EC proliferation, therefore, would have the potential to diminish rheumatoid inflammation. We have, therefore, studied the effects of gold sodium thiomalate (GST), auranofin, and gold chloride on the proliferation of human umbilical vein EC. GST suppressed both basal and EC growth factor-induced tritiated thymidine incorporation into EC in a dose-dependent fashion. Inhibition was observed with concentrations as low as 1 microgram/ml GST, 5 micrograms/ml gold chloride, and 0.1 microgram/ml auranofin, levels attainable in blood and synovium of patients. These results suggest that gold compounds have an antiangiogenic effect. The low concentrations inhibiting EC proliferation suggest that gold compounds may suppress rheumatoid synovitis by reducing the number of small blood vessels available for mononuclear cell infiltration and synovial tissue proliferation.

Full text

PDF
1440

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam M., Fietzek P., Kühn K. Investigations on the reaction of metals with collagen in vivo. 2. The formation of cross-links in the collagen of lathyritic rats after gold treatment in vivo. Eur J Biochem. 1968 Feb;3(4):411–414. doi: 10.1111/j.1432-1033.1967.tb19545.x. [DOI] [PubMed] [Google Scholar]
  2. Adam M., Kühn K. Investigations on the reaction of metals with collagen in vivo. 1. Comparison of the reaction of gold thiosulphate with collagen in vivo and vitro. Eur J Biochem. 1968 Feb;3(4):407–410. doi: 10.1111/j.1432-1033.1967.tb19544.x. [DOI] [PubMed] [Google Scholar]
  3. Ashida E. R., Johnson A. R., Lipsky P. E. Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. J Clin Invest. 1981 May;67(5):1490–1499. doi: 10.1172/JCI110179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Billings R., Grahame R., Marks V., Wood P. J., Taylor A. Blood and urine gold levels during chrysotherapy for rheumatoid arthritis. Rheumatol Rehabil. 1975 Feb;14(1):13–18. doi: 10.1093/rheumatology/14.1.13. [DOI] [PubMed] [Google Scholar]
  5. Bowersox J. C., Sorgente N. Chemotaxis of aortic endothelial cells in response to fibronectin. Cancer Res. 1982 Jul;42(7):2547–2551. [PubMed] [Google Scholar]
  6. Burge J. J., Fearon D. T., Austen K. F. Inhibition of the alternative pathway of complement by gold sodium thiomalate in vitro. J Immunol. 1978 May;120(5):1625–1630. [PubMed] [Google Scholar]
  7. Burger D. R., Ford D., Vetto R. M., Hamblin A., Goldstein A., Hubbard M., Dumonde D. C. Endothelial cell presentation of antigen to human T cells. Hum Immunol. 1981 Nov;3(3):209–230. doi: 10.1016/0198-8859(81)90019-7. [DOI] [PubMed] [Google Scholar]
  8. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  9. Ennis R. S., Granda J. L., Posner A. S. Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases. Arthritis Rheum. 1968 Dec;11(6):756–764. doi: 10.1002/art.1780110605. [DOI] [PubMed] [Google Scholar]
  10. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175–203. doi: 10.1016/s0065-230x(08)60946-x. [DOI] [PubMed] [Google Scholar]
  11. Fromer C. H., Klintworth G. K. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. Am J Pathol. 1975 Jun;79(3):537–554. [PMC free article] [PubMed] [Google Scholar]
  12. Gerber R. C., Paulus H. E., Bluestone R., Pearson C. M. Clinical response and serum gold levels in chrysotherapy. Lack of correlation. Ann Rheum Dis. 1972 Jul;31(4):308–310. doi: 10.1136/ard.31.4.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gottlieb N. L. Comparative pharmacokinetics of parenteral and oral gold compounds. J Rheumatol Suppl. 1982 Jul-Aug;8:99–109. [PubMed] [Google Scholar]
  14. Gottlieb N. L., Smith P. M., Smith E. M. Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy. Arthritis Rheum. 1972 Jan-Feb;15(1):16–22. doi: 10.1002/art.1780150103. [DOI] [PubMed] [Google Scholar]
  15. Grahame R., Billings R., Laurence M., Marks V., Wood P. J. Tissue gold levels after chrysotherapy. Ann Rheum Dis. 1974 Nov;33(6):536–539. doi: 10.1136/ard.33.6.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hirschberg H., Bergh O. J., Thorsby E. Antigen-presenting properties of human vascular endothelial cells. J Exp Med. 1980 Aug 1;152(2 Pt 2):249s–255s. [PubMed] [Google Scholar]
  17. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jessop J. D., Johns R. G. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate. Ann Rheum Dis. 1973 May;32(3):228–232. doi: 10.1136/ard.32.3.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Johnson R. L., Ziff M. Lymphokine stimulation of collagen accumulation. J Clin Invest. 1976 Jul;58(1):240–252. doi: 10.1172/JCI108455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kobayashi I., Ziff M. Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane. Arthritis Rheum. 1973 Jul-Aug;16(4):471–486. doi: 10.1002/art.1780160407. [DOI] [PubMed] [Google Scholar]
  21. Lipsky P. E., Ziff M. Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest. 1977 Mar;59(3):455–466. doi: 10.1172/JCI108660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lipsky P. E., Ziff M. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol. 1978 Mar;120(3):1006–1013. [PubMed] [Google Scholar]
  23. Lorber A., Cohen R. L., Chang C. C., Anderson H. E. Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients. Arthritis Rheum. 1968 Apr;11(2):170–177. doi: 10.1002/art.1780110207. [DOI] [PubMed] [Google Scholar]
  24. Maciag T., Mehlman T., Friesel R., Schreiber A. B. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science. 1984 Aug 31;225(4665):932–935. doi: 10.1126/science.6382607. [DOI] [PubMed] [Google Scholar]
  25. Martin B. M., Gimbrone M. A., Jr, Unanue E. R., Cotran R. S. Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Immunol. 1981 Apr;126(4):1510–1515. [PubMed] [Google Scholar]
  26. Mascarenhas B. R., Granda J. L., Freyberg R. H. Gold metabolism in patients with rheumatoid arthritis treated with gold compounds--reinvestigated. Arthritis Rheum. 1972 Jul-Aug;15(4):391–402. doi: 10.1002/art.1780150410. [DOI] [PubMed] [Google Scholar]
  27. Matsubara T., Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol. 1986 Nov 15;137(10):3295–3298. [PubMed] [Google Scholar]
  28. Miossec P., Cavender D., Ziff M. Production of interleukin 1 by human endothelial cells. J Immunol. 1986 Apr 1;136(7):2486–2491. [PubMed] [Google Scholar]
  29. Nechay B. R. Inhibition of adenosine triphosphatases by gold. Arthritis Rheum. 1980 Apr;23(4):464–470. doi: 10.1002/art.1780230409. [DOI] [PubMed] [Google Scholar]
  30. Nunez G., Ugolini V., Capra J. D., Stastny P. Monoclonal antibodies against human monocytes. II. Recognition of two distinct cell surface molecules. Scand J Immunol. 1982 Dec;16(6):515–523. doi: 10.1111/j.1365-3083.1982.tb00753.x. [DOI] [PubMed] [Google Scholar]
  31. Penneys N. S., Ziboh V., Gottlieb N. L., Katz S. Inhibition of prostaglandin synthesis and human epidermal enzymes by aurothiomalate in vitro: possible actions of gold in pemphigus. J Invest Dermatol. 1974 Oct;63(4):356–361. doi: 10.1111/1523-1747.ep12680840. [DOI] [PubMed] [Google Scholar]
  32. Persellin R. H., Ziff M. The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum. 1966 Feb;9(1):57–65. doi: 10.1002/art.1780090107. [DOI] [PubMed] [Google Scholar]
  33. Pober J. S., Gimbrone M. A., Jr, Cotran R. S., Reiss C. S., Burakoff S. J., Fiers W., Ault K. A. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med. 1983 Apr 1;157(4):1339–1353. doi: 10.1084/jem.157.4.1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Polverini P. J., Cotran P. S., Gimbrone M. A., Jr, Unanue E. R. Activated macrophages induce vascular proliferation. Nature. 1977 Oct 27;269(5631):804–806. doi: 10.1038/269804a0. [DOI] [PubMed] [Google Scholar]
  35. Postlethwaite A. E., Lachman L. B., Kang A. H. Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum. 1984 Sep;27(9):995–1001. doi: 10.1002/art.1780270905. [DOI] [PubMed] [Google Scholar]
  36. Rubinstein H. M., Dietz A. A. Serum gold. II. Levels in rheumatoid arthritis. Ann Rheum Dis. 1973 Mar;32(2):128–132. doi: 10.1136/ard.32.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schmidt J. A., Mizel S. B., Cohen D., Green I. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol. 1982 May;128(5):2177–2182. [PubMed] [Google Scholar]
  38. Schreiber A. B., Kenney J., Kowalski W. J., Friesel R., Mehlman T., Maciag T. Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6138–6142. doi: 10.1073/pnas.82.18.6138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schultz D. R., Volanakis J. E., Arnold P. I., Gottlieb N. L., Sakai K., Stroud R. M. Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds. Clin Exp Immunol. 1974 Jul;17(3):395–406. [PMC free article] [PubMed] [Google Scholar]
  40. Sigler J. W., Bluhm G. B., Duncan H., Sharp J. T., Ensign D. C., McCrum W. R. Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med. 1974 Jan;80(1):21–26. doi: 10.7326/0003-4819-80-1-21. [DOI] [PubMed] [Google Scholar]
  41. Stern D. M., Bank I., Nawroth P. P., Cassimeris J., Kisiel W., Fenton J. W., 2nd, Dinarello C., Chess L., Jaffe E. A. Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med. 1985 Oct 1;162(4):1223–1235. doi: 10.1084/jem.162.4.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stone K. J., Mather S. J., Gibson P. P. Selective inhibition of prostaglandin biosynthesis by gold salts and phenylbutazone. Prostaglandins. 1975 Aug;10(2):241–251. doi: 10.1016/0090-6980(75)90043-x. [DOI] [PubMed] [Google Scholar]
  43. Vernon-Roberts B. Action of gold salts on the inflammatory response and inflammatory cell function. J Rheumatol Suppl. 1979;5:120–129. [PubMed] [Google Scholar]
  44. Walz D. T., DiMartino M. J. Effect of anti-arthritic drugs on sulfhydryl reactivity of rat serum. Proc Soc Exp Biol Med. 1972 May;140(1):263–268. doi: 10.3181/00379727-140-36438. [DOI] [PubMed] [Google Scholar]
  45. Zvaifler N. J. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol. 1973;16(0):265–336. doi: 10.1016/s0065-2776(08)60299-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES